FMDRX
Price
$34.44
Change
-$0.04 (-0.12%)
Updated
Jul 31 closing price
Net Assets
9.45B
OANGX
Price
$41.25
Change
-$0.15 (-0.36%)
Updated
Jul 31 closing price
Net Assets
1.08B
Interact to see
Advertisement

FMDRX vs OANGX

FMDRX vs OANGX Comparison Chart in %
View a ticker or compare two or three
VS
FMDRX vs. OANGX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMDRX is a Hold and OANGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FMDRX has more cash in the bank: 9.45B vs. OANGX (1.08B). FMDRX pays higher dividends than OANGX: FMDRX (1.74) vs OANGX (1.27). FMDRX was incepted earlier than OANGX: FMDRX (13 years) vs OANGX (10 years). FMDRX (0.89) and OANGX (0.88) have similar cost to investors . OANGX is a more actively managed with annual turnover of: 68.00 vs. FMDRX (42.28). OANGX has a lower initial minimum investment than FMDRX: OANGX (250000) vs FMDRX (1000000). OANGX annual gain was more profitable for investors over the last year : 16.67 vs. FMDRX (9.64). OANGX return over 5 years is better than : 15.18 vs. FMDRX (12.18).
FMDRXOANGXFMDRX / OANGX
Total Expense Ratio0.890.88101%
Annual Report Gross Expense Ratio0.890.88101%
Fund Existence13 years10 years-
Gain YTD7.4245.688131%
Front LoadN/AN/A-
Min. Initial Investment1000000250000400%
Min. Initial Investment IRAN/AN/A-
Net Assets9.45B1.08B876%
Annual Yield % from dividends1.741.27137%
Returns for 1 year9.6416.6758%
Returns for 3 years17.3027.7662%
Returns for 5 years12.1815.1880%
Returns for 10 years27.87N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUOX18.330.13
+0.71%
Lazard US Equity Focus Open
TAVFX84.490.15
+0.18%
Third Avenue Value Instl
ZGFIX19.510.01
+0.05%
American Beacon Ninety One Gbl Frnchs R5
BIECX29.54-0.17
-0.57%
Brandes International Equity C
MRSJX29.37-0.17
-0.58%
MFS Research International R4